🇩🇰 Denmark Country × Condition
heart failure Clinical Trials in Denmark
Active clinical trials for heart failure with research sites in Denmark. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 3 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇩🇰 Denmark
Active Trials in Denmark (5)
NCT06180603
Recruiting
Strategy for Prompt and Effective Thoracentesis in the Emergency Department
Enrollment
188 pts
Country
🇩🇰 Denmark
University of Aarhus
View Trial → NCT07518446
Recruiting
Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)
Enrollment
2,800 pts
Country
🇩🇰 Denmark
Amager Hospital
View Trial → NCT04950218
Recruiting
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Enrollment
1,000 pts
Country
🇩🇰 Denmark
Herlev and Gentofte Hospital
View Trial → NCT06543173
Recruiting
Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator
Enrollment
62 pts
Country
🇩🇰 Denmark
University of Rochester
View Trial → NCT06694727 Phase 3
Recruiting
A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure
Enrollment
4,044 pts
Country
🇩🇰 Denmark
Tor Biering-Sørensen
View Trial → Frequently Asked Questions
How many heart failure clinical trials are active in Denmark?
There are currently 5 active clinical trials for heart failure with sites in Denmark, of which 5 are actively recruiting patients.
How can I join a heart failure clinical trial in Denmark?
To join a heart failure clinical trial in Denmark, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Denmark directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are heart failure trials in Denmark?
Active heart failure trials in Denmark span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology